(Q35826832)

3

1 reference

10 August 2017

Takenori Takahata

4

1 reference

10 August 2017

Kazunobu Sugawara

5

1 reference

10 August 2017

Akihiro Munakata

6

1 reference

10 August 2017

Tomonori Tateishi

British Journal of Clinical Pharmacology

7

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

10 August 2017

1 reference

10 August 2017

59

1 reference

10 August 2017

302-309

1 reference

10 August 2017

3

1 reference

10 August 2017

Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

The pharmacokinetics of sumatriptan when administered with clarithromycin in healthy volunteers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Genetic polymorphism of CYP2C19 and lansoprazole pharmacokinetics in Japanese subjects

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Identification of the human P450 enzymes involved in lansoprazole metabolism.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Clinical pharmacokinetics of lansoprazole.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Pharmacokinetic interactions of the macrolide antibiotics

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Genetic polymorphism of S-mephenytoin hydroxylation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes

27 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02329.X

Different contribution of CYP2C19 in the in vitro metabolism of three proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02329.X

Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02329.X

Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02329.X

Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02329.X

Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02329.X

Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02329.X

Pharmacokinetics of lansoprazole, amoxicillin and clarithromycin after simultaneous and single administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02329.X

Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02329.X

Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02329.X

Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02329.X

Determination of lansoprazole and two of its metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography: application to measuring CYP2C19 activity

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Effect of clarithromycin on steady-state digoxin concentrations

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Nomenclature for human CYP2D6 alleles.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884793

Interaction between FK 506 and clarithromycin in a renal transplant patient

24 September 2018

1 reference

12 December 2020

Possible role of the intestinal P-450 enzyme system in a cyclosporine-clarithromycin interaction

1 reference

12 December 2020

Metabolic disposition of lansoprazole in relation to the S-mephenytoin 4'-hydroxylation phenotype status

1 reference

12 December 2020

Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer

1 reference

12 December 2020

Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans

1 reference

12 December 2020

Determination of lansoprazole and its metabolites in plasma by high-performance liquid chromatography using a loop column

1 reference

12 December 2020

The effects of lansoprazole, a new H+,K+-ATPase inhibitor, on gastric pH and serum gastrin

1 reference

12 December 2020